RGMb is a novel binding partner for PD-l2 and its engagement with PD-l2 promotes respiratory tolerance

Journal of Experimental Medicine

Volumn 211, Issue 5, 2014, Pages 943-959

  Xiao, Yanping ^a   Yu, Sanhong ^b   Zhu, Baogong ^a   Bedoret, Denis ^b   Bu, Xia ^a   Duke Cohan, Loise M Francisco ^a   Umetsu, Dale T ^b   Sharpe, Arlene H ^a,c   DeKruyff, Rosemarie H ^b   Freeman, Gordon J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 2; REPULSIVE GUIDANCE MOLECULE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTHMA; CANCER CELL LINE; CANCER IMMUNOTHERAPY; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; RESPIRATORY FUNCTION; RESPIRATORY TOLERANCE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; LUNG; MACROPHAGES, ALVEOLAR; MICE; NERVE TISSUE PROTEINS; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROTEIN BINDING;

EID: 84899758346     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130790     Document Type: Article

References (54)

1. Akbari, O., P. Stock, A.K. Singh, V. Lombardi, W.L. Lee, G.J. Freeman, A.H. Sharpe, D.T. Umetsu, and R.H. Dekruyff. 2010. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol. 3:81-91. http://dx.doi.org/10.1038/mi.2009.112
2. Albacker, L.A., S. Yu, D. Bedoret, W.L. Lee, S.E. Umetsu, S. Monahan, G.J. Freeman, D.T. Umetsu, and R.H. Dekruyff. 2013. TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells. Mucosal Immunol. 6:580-590. 10.1038/mi.2012.100.
3. Bedoret, D., H. Wallemacq, T. Marichal, C. Desmet, F. Quesada Calvo, E. Henry, R. Closset, B. Dewals, C. Thielen, P. Gustin, et al. 2009. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119:3723-3738. http://dx.doi.org/10.1172/JCI39717
4. Bell, C.H., E. Healey, S. van Erp, B. Bishop, C. Tang, R.J. Gilbert, A.R. Aricescu, R.J. Pasterkamp, and C. Siebold. 2013. Structure of the repulsive guidance molecule (RGM)-neogenin signaling hub. Science. 341:77-80. http://dx.doi.org/10.1126/science.1232322
5. Bragdon, B., O. Moseychuk, S. Saldanha, D. King, J. Julian, and A. Nohe. 2011. Bone morphogenetic proteins: a critical review. Cell. Signal. 23:609-620. http://dx.doi.org/10.1016/j.cellsig.2010.10.003
6. Chuquimia, O.D., D.H. Petursdottir, M.J. Rahman, K. Hartl, M. Singh, and C. Fernández. 2012. The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems. PLoS ONE. 7:e32125. http://dx.doi.org/10.1371/journal.pone.0032125
7. Conrad, S., H. Genth, F. Hofmann, I. Just, and T. Skutella. 2007. Neogenin-RGMa signaling at the growth cone is bone morphogenetic proteinindependent and involves RhoA, ROCK, and PKC. J. Biol. Chem. 282:16423-16433. http://dx.doi.org/10.1074/jbc. M610901200
8. Conrad, S., F. Stimpfle, S. Montazeri, J. Oldekamp, K. Seid, G. Alvarez-Bolado, and T. Skutella. 2010. RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo. Mol. Cell. Neurosci. 43:222-231. http://dx.doi.org/10.1016/j.mcn.2009.11.003
9. Corradini, E., J.L. Babitt, and H.Y. Lin. 2009. The RGM/DRAGON family of BMP co-receptors. Cytokine Growth Factor Rev. 20:389-398. http://dx.doi.org/10.1016/j.cytogfr.2009.10.008
10. Freeman, G.J., A.S. Freedman, J.M. Segil, G. Lee, J.F. Whitman, and L.M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143: 2714-2722.
11. Galligan, C.L., E. Baig, V. Bykerk, E.C. Keystone, and E.N. Fish. 2007. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun. 8:480-491. http://dx.doi.org/10.1038/sj.gene.6364400
12. GeurtsvanKessel, C.H., and B.N. Lambrecht. 2008. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol. 1:442-450. http://dx.doi.org/10.1038/mi.2008.39
13. Graf, D., S. Nethisinghe, D.B. Palmer, A.G. Fisher, and M. Merkenschlager. 2002. The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J. Exp. Med. 196:163-171. http://dx.doi.org/10.1084/jem.20020276
14. Hager-Theodorides, A.L., S.V. Outram, D.K. Shah, R. Sacedon, R.E. Shrimpton, A. Vicente, A. Varas, and T. Crompton. 2002. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J. Immunol. 169:5496-5504.
15. Hagihara, M., M. Endo, K. Hata, C. Higuchi, K. Takaoka, H. Yoshikawa, and T. Yamashita. 2011. Neogenin, a receptor for bone morphogenetic proteins. J. Biol. Chem. 286:5157-5165. http://dx.doi.org/10.1074/jbc. M110.180919
16. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779. http://dx.doi.org/10.1084/jem.194.6.769
17. Hirano, N., M.O. Butler, Z. Xia, S. Ansén, M.S. von Bergwelt-Baildon, D. Neuberg, G.J. Freeman, and L.M. Nadler. 2006. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood. 107:1528-1536. http://dx.doi.org/10.1182/blood-2005-05-2073
18. Holt, P.G., and J.W. Upham. 2004. The role of dendritic cells in asthma. Curr. Opin. Allergy Clin. Immunol. 4:39-44. http://dx.doi.org/10.1097/00130832-200402000-00009
19. Hoyne, G.F., B.A. Askonas, C. Hetzel, W.R. Thomas, and J.R. Lamb. 1996. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335-342. http://dx.doi.org/10.1093/intimm/8.3.335
20. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090331
21. Kim, J., A.C. Myers, L. Chen, D.M. Pardoll, Q.A. Truong-Tran, A.P. Lane, J.F. McDyer, L. Fortuno, and R.P. Schleimer. 2005. Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 33:280-289. http://dx.doi.org/10.1165/rcmb.2004-0129OC
22. König, K., D. Gatidou, T. Granja, J. Meier, P. Rosenberger, and V. Mirakaj. 2012. The axonal guidance receptor neogenin promotes acute inflammation. PLoS ONE. 7:e32145. http://dx.doi.org/10.1371/journal.pone.0032145
23. Lam, H.C., A.M. Choi, and S.W. Ryter. 2011. Isolation of mouse respiratory epithelial cells and exposure to experimental cigarette smoke at air liquid interface. J. Vis. Exp. 48:2513.
24. Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268. http://dx.doi.org/10.1038/85330
25. Lesterhuis, W.J., H. Steer, and R.A. Lake. 2011. PD-L2 is predominantly expressed by Th2 cells. Mol. Immunol. 49:1-3. http://dx.doi.org/10.1016/j.molimm.2011.09.014
26. Li, J., L. Ye, H.G. Kynaston, and W.G. Jiang. 2012a. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells. Int. J. Oncol. 40:544-550.
27. Li, J., L. Ye, A.J. Sanders, and W.G. Jiang. 2012b. Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling. J. Cell. Biochem. 113:2523-2531. http://dx.doi.org/10.1002/jcb.24128
28. Liu, X., J.X. Gao, J. Wen, L. Yin, O. Li, T. Zuo, T.F. Gajewski, Y.X. Fu, P. Zheng, and Y. Liu. 2003. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp. Med. 197:1721-1730. http://dx.doi.org/10.1084/jem.20022089
29. Liu, W., X. Li, Y. Zhao, X.M. Meng, C. Wan, B. Yang, H.Y. Lan, H.Y. Lin, and Y. Xia. 2013. Dragon (RGMb) inhibits E-Cadherin expression and induces apoptosis in renal tubular epithelial cells. J. Biol. Chem. 288:31528-31539. http://dx.doi.org/10.1074/jbc. M113.517573
30. Lu, L., J. Ma, X. Wang, J. Wang, F. Zhang, J. Yu, G. He, B. Xu, D.D. Brand, D.A. Horwitz, et al. 2010. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur. J. Immunol. 40:142-152. http://dx.doi.org/10.1002/eji.200939618
31. Messal, N., N.E. Serriari, S. Pastor, J.A. Nunés, and D. Olive. 2011. PD-L2 is expressed on activated human T cells and regulates their function. Mol. Immunol. 48:2214-2219. http://dx.doi.org/10.1016/j.molimm.2011.06.436
32. Mirakaj, V., C. Jennewein, K. König, T. Granja, and P. Rosenberger. 2012. The guidance receptor neogenin promotes pulmonary inflammation during lung injury. FASEB J. 26:1549-1558. http://dx.doi.org/10.1096/fj.11-200063
33. Mkrtichyan, M., Y.G. Najjar, E.C. Raulfs, L. Liu, S. Langerman, G. Guittard, L. Ozbun, and S.N. Khleif. 2012. B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets. J. Immunol. 189:2338-2347. http://dx.doi.org/10.4049/jimmunol.1103085
34. Muramatsu, R., T. Kubo, M. Mori, Y. Nakamura, Y. Fujita, T. Akutsu, T. Okuno, J. Taniguchi, A. Kumanogoh, M. Yoshida, et al. 2011. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis. Nat. Med. 17:488-494. http://dx.doi.org/10.1038/nm.2321
35. Pardoll, D.M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 12:252-264. http://dx.doi.org/10.1038/nrc3239
36. Pfistershammer, K., C. Klauser, W.F. Pickl, J. Stöckl, J. Leitner, G. Zlabinger, O. Majdic, and P. Steinberger. 2006. No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation. Eur. J. Immunol. 36:1104-1113. http://dx.doi.org/10.1002/eji.200535344
37. Ritprajak, P., M. Hashiguchi, H. Akiba, H. Yagita, K. Okumura, and M. Azuma. 2012. Antibodies against B7-DC with differential binding properties exert opposite effects. Hybridoma (Larchmt). 31:40-47. http://dx.doi.org/10.1089/hyb.2011.0087
38. Rosendahl, A., E. Pardali, M. Speletas, P. Ten Dijke, C.H. Heldin, and P. Sideras. 2002. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am. J. Respir. Cell Mol. Biol. 27:160-169. http://dx.doi.org/10.1165/ajrcmb.27.2.4779
39. Samad, T.A., A. Rebbapragada, E. Bell, Y. Zhang, Y. Sidis, S.J. Jeong, J.A. Campagna, S. Perusini, D.A. Fabrizio, A.L. Schneyer, et al. 2005. DRAGON, a bone morphogenetic protein co-receptor. J. Biol. Chem. 280:14122-14129. http://dx.doi.org/10.1074/jbc. M410034200
40. Severyn, C.J., U. Shinde, and P. Rotwein. 2009. Molecular biology, genetics and biochemistry of the repulsive guidance molecule family. Biochem. J. 422:393-403. http://dx.doi.org/10.1042/BJ20090978
41. Shin, T., G. Kennedy, K. Gorski, H. Tsuchiya, H. Koseki, M. Azuma, H. Yagita, L. Chen, J. Powell, D. Pardoll, and F. Housseau. 2003. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 198:31-38. http://dx.doi.org/10.1084/jem.20030242
42. Singh, A.K., P. Stock, and O. Akbari. 2011. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy. 66:155-162. http://dx.doi.org/10.1111/j.1398-9995.2010.02458.x
43. Strickland, D.H., J.W. Upham, and P.G. Holt. 2010. Epithelial-dendritic cell interactions in allergic disorders. Curr. Opin. Immunol. 22:789-794. http://dx.doi.org/10.1016/j.coi.2010.10.019
44. Tian, C., and J. Liu. 2013. Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling. Mol. Reprod. Dev. 80:700-717.
45. Topalian, S.L., F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, J.D. Powderly, R.D. Carvajal, J.A. Sosman, M.B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366:2443-2454. http://dx.doi.org/10.1056/NEJMoa1200690
46. Tseng, S.Y., M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, S.I. Pai, A. Shalabi, T. Shin, D.M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:839-846. http://dx.doi.org/10.1084/jem.193.7.839
47. Tsitoura, D.C., R.H. DeKruyff, J.R. Lamb, and D.T. Umetsu. 1999. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J. Immunol. 163:2592-2600.
48. Wang, S., J. Bajorath, D.B. Flies, H. Dong, T. Honjo, and L. Chen. 2003. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:1083-1091. http://dx.doi.org/10.1084/jem.20021752
49. Wu, Q., C.C. Sun, H.Y. Lin, and J.L. Babitt. 2012. Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs). PLoS ONE. 7:e46307. http://dx.doi.org/10.1371/journal.pone.0046307
50. Xia, Y., V. Cortez-Retamozo, V. Niederkofler, R. Salie, S. Chen, T.A. Samad, C.C. Hong, S. Arber, J.M. Vyas, R. Weissleder, et al. 2011. Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. J. Immunol. 186:1369-1376. http://dx.doi.org/10.4049/jimmunol.1002047
51. Yasmin, N., T. Bauer, M. Modak, K. Wagner, C. Schuster, R. Köffel, M. Seyerl, J. Stöckl, A. Elbe-Bürger, D. Graf, and H. Strobl. 2013. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation. J. Exp. Med. 210:2597-2610. http://dx.doi.org/10.1084/jem.20130275
52. Yoshioka, Y., M. Ono, M. Osaki, I. Konishi, and S. Sakaguchi. 2012. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur. J. Immunol. 42: 749-759. http://dx.doi.org/10.1002/eji.201141702
53. Zhang, Y., Y. Chung, C. Bishop, B. Daugherty, H. Chute, P. Holst, C. Kurahara, F. Lott, N. Sun, A.A. Welcher, and C. Dong. 2006. Regulation of T cell activation and tolerance by PDL2. Proc. Natl. Acad. Sci. USA. 103:11695-11700. http://dx.doi.org/10.1073/pnas.0601347103
54. Zhong, X., and T.L. Rothstein. 2011. L2pB1: a new player in autoimmunity. Mol. Immunol. 48:1292-1300.2010.12.006